A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple-Ascending Doses of BGB-16673 in Adults With Chronic Spontaneous Urticaria - BeOne

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple-Ascending Doses of BGB-16673 in Adults With Chronic Spontaneous Urticaria

Ask to Join

BeOne Study ID

BGB-16673-107

ClinicalTrials.gov ID

NCT07005713

Study Overview

Sex: All

Age: 18 Years / 70 Years

No Study Documents

Locations

Study Overview

Sex: All

Age: 18 Years / 70 Years

No Study Documents